Genomic alterations in primary gastric cancers analyzed by comparative genomic hybridization and clinicopathological factors

Hepato-Gastroenterology

Volumn 47, Issue 33, 2000, Pages 658-662

  Nakanishi, Masayoshi ^a   Sakakura, Chohei ^a   Fujita, Yoshifumi ^a   Yasuoka, Rie ^a   Aragane, Hideki ^a   Koide, Kazuma ^a   Hagiwara, Akeo ^a   Yamaguchi, Toshiharu ^a   Nakamura, Yusuke ^b   Tatsuo, Abe ^a   Inazawa, Johji ^a,b,c   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CGH; Chromosomal aberrations; Primary gastric cancer

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 19Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; DNA HYBRIDIZATION; DNA SEQUENCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; SIGNET RING CARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; CARCINOMA, SIGNET RING CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; HUMANS; STOMACH NEOPLASMS;

EID: 0034093976     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 1 Whelan SL, Parkin DM, Masuyer E: Trends in cancer incidence and mortality. Lyon: IARC Scientific, 1993.
2. 2 Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P: Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23:307-316.
3. 3 Vidgren V, Varis A, Kokkola A, Monni O, Puolakkainen P, Nordling S, Forozan F, Kallioniemi A, Vakkari ML, Kivilaakso E, Knuutila S: Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer. Genes Chromosomes Cancer. 1999; 24:24-29.
4. 4 Powell SM, Cummings OW, Mullen JA, Asghar A, Fuga G, Piva P, Minacci C, Megha T, Tosi P, Jackson CE: Characterization of the APC gene in sporadic gastric adenocarcinomas. Oncogene 1996; 12:1953-1959.
5. 5 Fang DC, Jass JR, Wang DX: Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol 1998; 51:593-596.
6. 6 Nishi M, Omori Y, Miwa K: Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara & Co., LTD., 1995.
7. 7 Otsuji E, Yamaguchi T, Sawai K, Takahashi T: Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 1998; 67:216-220.
8. 8 Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Kikuchi S, Yamauchi H: Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types. Tohoku J Exp Med 1998; 186:121-130. (Review)
9. 9 Kim JP, Kim SC, Yang HK: Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 1994; 3:221-227.
10. 10 Maehara Y, Sakaguchi Y, Moriguchi S, Orita H, Korenaga D, Kohnoe S, Sugimachi K: Signet ring cell carcinoma of the stomach. Cancer 1992; 69:1645-1650.
11. 11 Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258:818-821.
12. 12 Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J: Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24:299-305.
13. 13 Sakakura C, Hagiwara A, Taniguchi H, Yamaguchi T, Yamagishi H, Takahashi T, Koyama K, Nakamura Y, Abe T, Inazawa J: Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br J Cancer 1999; 80:2034-2039.
14. 14 Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, Kimuru A, Nakamura Y, Inazawa J, Abe T, Yamagishi H: Amplification and overexpression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer. (In press)
15. 15 Larramendy ML, el-Rifai W, Kokkola A, Puolakkainen P, Monni O, Salovaara R, Aarnio M, Knuutila S: Comparative genomic hybridization reveals differences in DNA copy number changes between sporadic gastric carcinomas and gastric carcinomas from patients with hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 1998; 106:62-65.
16. 16 Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S: Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet 1998; 107:32-36.
17. 17 Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E: Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991; 51:2926-2931.
18. 18 Choi SW, Park SW, Lee KY, Kim KM, Chung YJ, Rhyu MG: Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene 1998; 17:2655-2659.
19. 19 Poremba C, Yandell DW, Huang Q, Little JB, Mellin W, Schmid KW, Bocker W, Dockhorn-Dworniczak B: Frequency and spectrum of p53 mutations in gastric cancer - a molecular genetic and immunohistochemical study. Virchows Arch 1995; 426(5):447-455.
20. 20 El-Rifai W, Harper JC, Cummings OW, Hyytinen ER, Frierson HF Jr, Knuutila S, Powell SM: Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 1998; 58:34-37.
21. 21 Korn WM, Yasutake T, Kuo WL, Warren RS, Collins C, Tomita M, Gray J, Waldman FM: Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999; 25:82-90.
22. 22 Nakao K, Shibusawa M, Tsunoda A, Yoshizawa H, Murakami M, Kusano M, Uesugi N, Sasaki K: Genetic changes in primary colorectal cancer by comparative genomic hybridization. Surg Today 1998; 28:567-569.
23. 23 Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91:2156-2160.
24. 24 Courjal F, Theillet C: Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 1997; 57:4368-4377.
25. 25 Mahlamaki EH, Hoglund M, Gorunova L, Karhu R, Dawiskiba S, Andren-Sandberg A, Kallioniemi OP, Johansson B: Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997; 20:383-391.
26. 26 Nanashima A, Yamaguchi H, Yasutake T, Sawai T, Kusano H, Tagawa Y, Nakagoe T, Ayabe H: Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers. Dig Dis Sci 1997; 42:1388-1393.
27. 27 Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M, Horii A: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997; 19:161-169.
28. 28 Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997; 277:965-968.
29. 29 Bautista S, Valles H, Walker RL, Anzick S, Zeillinger R, Meltzer P, Theillet C: In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin Cancer Res 1998; 4:2925-2929.
30. 30 Sen S, Zhou H, White RA: A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997; 14:2195-2200.
31. 31 Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189-193.
32. 32 Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998; 396:699-703.
33. 33 Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999; 274:13733-13736.
34. 34 Yonemura Y, Kimura H, Fushida S, Tugawa K, Nakai Y, Kaji M, Fonseca L, Yamaguchi A, Miyazaki I: Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993; 71:2448-2453.
35. 35 Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S: 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 1997; 20:38-43.